256 related articles for article (PubMed ID: 19336569)
1. Copy number alterations that predict metastatic capability of human breast cancer.
Zhang Y; Martens JW; Yu JX; Jiang J; Sieuwerts AM; Smid M; Klijn JG; Wang Y; Foekens JA
Cancer Res; 2009 May; 69(9):3795-801. PubMed ID: 19336569
[TBL] [Abstract][Full Text] [Related]
2. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
3. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
[TBL] [Abstract][Full Text] [Related]
4. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
[TBL] [Abstract][Full Text] [Related]
5. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.
Foekens JA; Atkins D; Zhang Y; Sweep FC; Harbeck N; Paradiso A; Cufer T; Sieuwerts AM; Talantov D; Span PN; Tjan-Heijnen VC; Zito AF; Specht K; Hoefler H; Golouh R; Schittulli F; Schmitt M; Beex LV; Klijn JG; Wang Y
J Clin Oncol; 2006 Apr; 24(11):1665-71. PubMed ID: 16505412
[TBL] [Abstract][Full Text] [Related]
6. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
[TBL] [Abstract][Full Text] [Related]
7. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
[TBL] [Abstract][Full Text] [Related]
8. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer.
Yu JX; Sieuwerts AM; Zhang Y; Martens JW; Smid M; Klijn JG; Wang Y; Foekens JA
BMC Cancer; 2007 Sep; 7():182. PubMed ID: 17894856
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
11. Validation of 70-gene prognosis signature in node-negative breast cancer.
Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
[TBL] [Abstract][Full Text] [Related]
12. Prediction of breast cancer prognosis by gene expression profile of TP53 status.
Takahashi S; Moriya T; Ishida T; Shibata H; Sasano H; Ohuchi N; Ishioka C
Cancer Sci; 2008 Feb; 99(2):324-32. PubMed ID: 18271932
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Hess KR; Anderson K; Symmans WF; Valero V; Ibrahim N; Mejia JA; Booser D; Theriault RL; Buzdar AU; Dempsey PJ; Rouzier R; Sneige N; Ross JS; Vidaurre T; Gómez HL; Hortobagyi GN; Pusztai L
J Clin Oncol; 2006 Sep; 24(26):4236-44. PubMed ID: 16896004
[TBL] [Abstract][Full Text] [Related]
15. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
16. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
17. Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
de Tayrac M; Etcheverry A; Aubry M; Saïkali S; Hamlat A; Quillien V; Le Treut A; Galibert MD; Mosser J
Genes Chromosomes Cancer; 2009 Jan; 48(1):55-68. PubMed ID: 18828157
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer.
Thomassen M; Tan Q; Eiriksdottir F; Bak M; Cold S; Kruse TA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5355-60. PubMed ID: 17875763
[TBL] [Abstract][Full Text] [Related]
19. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
Zhang Y; Sieuwerts AM; McGreevy M; Casey G; Cufer T; Paradiso A; Harbeck N; Span PN; Hicks DG; Crowe J; Tubbs RR; Budd GT; Lyons J; Sweep FC; Schmitt M; Schittulli F; Golouh R; Talantov D; Wang Y; Foekens JA
Breast Cancer Res Treat; 2009 Jul; 116(2):303-9. PubMed ID: 18821012
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.
Folgueira MA; Carraro DM; Brentani H; Patrão DF; Barbosa EM; Netto MM; Caldeira JR; Katayama ML; Soares FA; Oliveira CT; Reis LF; Kaiano JH; Camargo LP; Vêncio RZ; Snitcovsky IM; Makdissi FB; e Silva PJ; Góes JC; Brentani MM
Clin Cancer Res; 2005 Oct; 11(20):7434-43. PubMed ID: 16243817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]